Top 5 Large-cap gainers and losers this week!
List of top 5 gainers and losers this week in the Large-cap space.
Stock market bulls were blasted off by Vladimir Putin’s advance into Ukrainian territory that also tore down all defences on Dalal Street. Benchmark indices recorded their fourth-worst point-wise fall in history on Thursday. In the period from Friday i.e. February 18 to February 24, the blue-chip NSE Nifty 50 index declined 5.95% from 17,276 to 16,247. Similarly, the S&P BSE Sensex registered a decline of 5.71% from 57,382 to 54,529.
Among the sectoral indices, S&P BSE Consumer durables (-3.58%) and S&P Bse Fast Moving Consumer Goods (-5.31%) were the least impacted in the previous 5 trading sessions, whereas the S&P Bse Realty (-8.37%) and S&P BSE Oil & Gas (-8.31%) were among those most impacted.
Let us have a look at the top gainers and losers in the large-cap space during this period.
Shares of Abbott India were buzzing on the bourses this week. The scrip rose 2.47% in the past 5 trading sessions, closing at Rs 16,777.60 on Thursday, and was among the top gainers among the Large Caps during this period. They have released Q3 results a few days back, where revenue was 11.5% up YoY, operating profit was 12% up YoY, while margins stayed flat with a 13% increase in net profit. In the last one-month share was trading volatile with anticipation of results and post result reaction.
Shares of Gland Pharma were among the large caps stocks that rallied the most this week, rising 2.26% to close at Rs 3,296.15 on Thursday. The previous week between 11 February and 18 February share was in the downtrend with a 9% down in that period. Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest-growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets.
Torrent Pharmaceuticals was among the top performers among the large caps this week and was up by 0.44% in the last 5 trading sessions, closing at Rs 2,669 on Thursday. Shares of Torrent Pharmaceuticals tanked about 15% in the last one month post the Q3 result announcement. It reported a weak set of numbers for the quarter. Revenue growth was at mid-single-digit and margins are in pressure along with bottom line degrowth of 16%. Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical companies engaged in the research, development, manufacturing and marketing of generic pharmaceutical formulations.
Start Investing Now!
Open Free Demat Account in 5 mins